We are live on ! Find out more
KALA icon

KALA BIO

17 hedge funds and large institutions have $24M invested in KALA BIO in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,195% more capital inflows, than outflows

Capital inflows: $9.18M | Capital outflows: $709K

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

29.13% more ownership

Funds ownership: 45.92% → 75.06% (+29%)

21% more funds holding

Funds holding: 14 → 17 (+3)

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KALA Hedge Fund Activity: Q4 2024 in Review

17 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2024, worth a combined $24M — up 99% from $12.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new KALA positions and 2 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $3.8M. The largest seller was ADAR1 Capital Management, cutting an estimated $539K.

  • 17 institutional investors held KALA BIO (KALA) as of Q4 2024, up from 14 in Q3 2024.
  • Funds reported $24M of KALA BIO stock for Q4 2024, up 99% quarter-over-quarter.
  • 5 funds opened new KALA BIO positions in Q4 2024 and 2 closed out, a net change of +3 holders.
  • The largest KALA BIO buyer in Q4 2024 was Cormorant Asset Management, an estimated $3.8M added.
  • The largest KALA BIO seller in Q4 2024 was ADAR1 Capital Management, an estimated $539K sold.

Based on aggregated 13F filings for Q4 2024.